🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to investigate the efficacy and safety of long...
Status
Completed
Location
Kameda Medical Center
Start Date
2018-02-18
Trial ID
NCT03416374
Treatments Being Tested
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cell (...
Status
Active Not Recruiting
Location
The University of Arizona Cancer Center - North Campus /ID# 242219
Start Date
2022-06-14
Trial ID
NCT05283720
The purpose of this study is to: * assess the effectiveness of lenalidomid...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2008-06
Trial ID
NCT00704691
Treatments Being Tested
A phase 3, randomized, open-label, parallel-controlled, multi-center study ...
Status
Completed
Location
Capital Medical University (CMU) - Beijing Chao-Yang Hospital
Start Date
2019-03-27
Trial ID
NCT03952091
Treatments Being Tested
The purpose of this study is to evaluate the combination of Revlimid® (lena...
Status
Terminated
Location
Indiana University Melvin and Bren Simon Cancer Center
Start Date
2011-05
Trial ID
NCT01348503
Treatments Being Tested
This Phase II, open-label, multicenter study will evaluate teclistamab in c...
Status
Not Yet Recruiting
Location
AUH
Start Date
2026-09-01
Trial ID
NCT07757412
Treatments Being Tested
Our hypothesis is that treating relapsed or refractory multiple myeloma wit...
Status
Terminated
Location
Weill Cornell Medical College
Start Date
2014-02
Trial ID
NCT02030483
Treatments Being Tested
The purpose of the study is to examine efficacy and safety of epcoritamab w...
Status
Terminated
Location
UW Cancer Center at ProHealth Care
Start Date
2023-03-06
Trial ID
NCT05660967
Treatments Being Tested
Primary Objective: To compare the complete response rate (CR rate) after in...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-03-23
Trial ID
NCT07505849
Treatments Being Tested
This study will evaluate the efficacy and safety of mosunetuzumab in combin...
Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2021-10-27
Trial ID
NCT04712097
Treatments Being Tested